Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diabetes is a major predictor of death from heart disease and stroke; its impact on nonvascular mortality, including specific cancers, is less understood. We examined the association of diabetes with cause-specific mortality, including deaths from specific cancers. RESEARCH DESIGN AND METHODS: A prospective cohort of 1,053,831 U.S. adults, without cancer at baseline, enrolled in the Cancer Prevention Study-II in 1982 and was followed for mortality until December 2008. At baseline, participants completed a self-administered questionnaire that included information on diabetes, smoking, physical activity, height, and weight. Multivariable-adjusted relative risks (RRs) (95% CI) were estimated using Cox proportional hazards regression. RESULTS: During 26 years of follow-up, 243,051 men and 222,109 women died. In multivariable models that controlled for age, BMI, and other variables, diabetes was associated with higher risk of all-cause mortality (women RR 1.90 [95% CI 1.87–1.93]; men 1.73 [1.70–1.75]). Among women, diabetes was associated with higher risk of death from cancers of the liver (1.40 [1.05–1.86]), pancreas (1.31 [1.14–1.51]), endometrium (1.33 [1.08–1.65]), colon (1.18 [1.04–1.33]), and breast (1.16 [1.03–1.29]). Among men, diabetes was associated with risk of death from cancers of the breast (4.20 [2.20–8.04]), liver (2.26 [1.89–2.70]), oral cavity and pharynx (1.44 [1.07–1.94]), pancreas (1.40 [1.23–1.59]), bladder (1.22 [1.01–1.47]), colon (1.15 [1.03–1.29]), and (inversely) prostate (0.88 [0.79–0.97]). Diabetes was also associated with higher risks of death involving the circulatory system, respiratory system, digestive system, genitourinary system, and external causes/accidental deaths. CONCLUSIONS: Diabetes is associated with higher risk of death for many diseases, including several specific forms of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The main limitation of these studies is the wide variation in methodologies including differences in the type, formulation, concentration, and duration of exposure to probiotics.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1710]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several RCTs and systematic reviews/meta-analyses have noted a positive effect of probiotics on glucose, A1C, lipids, and BP.1705–1714”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1710]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“The global prevalence of adults with diabetes is projected to reach 366 million in 2030, more than double the estimated prevalence for 2000 (1).”
BackgroundJemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“BMI, a major risk factor for endometrial cancer incidence (35) and mortality (36).”
BackgroundRenehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219 · cited 1×
“BMI, a major risk factor for endometrial cancer incidence (35) and mortality (36).”
BackgroundThe Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · cited 2×
“Men and women with diabetes also experience about twofold higher risks of death from macrovascular disease, including heart disease and stroke (2,3).”
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366 · cited 2×
“Consistent with other prospective studies (6,18) and the conclusion from an expert report (8), we did not observe an association between diabetes and lung cancer mortality.”
BackgroundResultSelf-citationAssociation Between Smoking and Risk of Bladder Cancer Among Men and Women
Freedman, N. D. (2011) · JAMA · doi:10.1001/jama.2011.1142 · Cited by 1,141 · cited 1×
“Cigarette smoking is the primary risk factor for bladder cancer (31) and a weak risk factor for diabetes (32); thus, inclusion of smoking data in this study is a strength.”
BackgroundDiabetes and Cancer: A Consensus Report
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,055
Self-citationFasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 988 · cited 1×
“Only one of these other studies stratified associations by sex; there was a higher risk of bladder cancer mortality among men, but results among women were not presented (5).”
Research works printed but not linked: 2
- Centers for Disease Control and Prevention, 2011, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011
- World Health Organization, 1985, International Classification for Diseases
Cited by
Items 301–351 of 351
Mouse Models Used to Study the Effects of Diabetes, Insulin, and IGFs on Cancer
Zelenko, Z., LeRoith, D., & Gallagher, E. J. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_8
“Both obesity and T2D have been associated with more advanced stages of a number of cancers at presentation, resistance to therapy, and recurrence; all of these are factors that contribute to greater cancer mortality [13–16].”
BackgroundThe Epidemiology of Macrovascular Complications of Diabetes in Finland 1992-2002
Winell, K. (2013) · Helda - University of Helsinki Institutional Repository · Cited by 2
Characterization of adverse events during the treatment with heberprot-p® in four cuban provinces
Crespo, A. R. Á., Carbonell, L. A., Alos, I. B. Y., Milián, A. J. G., & Miragaya, M. A. M. (2015) · Horizonte Sanitario · doi:10.19136/hs.a14n2.950
Becker, A. D., de Lima, E. D. S., Ledur, P. D. S., & Schaan, B. D. (2014) · Americanae (AECID Library)
Occurrence of noncirrhotic HCC in NAFLD
Torres, D. M., & Harrison, S. A. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch7
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.869
Hypertension and diabetes treatments and risk of adverse outcomes among breast cancer patients
Chen, L. (2016) · ResearchWorks at the University of Washington (University of Washington)
The role of activation of insulin-like growth factors in colorectal cancer
Walkiewicz, K. W., Nowakowska‐Zajdel, E., Strzelczyk, J. K., Walczak, M., Copija, A., Janion, K., & Muc‐Wierzgoń, M. (2017) · Oncoreview · doi:10.24292/01.or.200717
Effects of diabetes mellitus on gallbladder
Alshalawi, B., Almuslam, A., Alqahtani, R. A., Al-Bokhari, A.-H., Alnajjar, W. Z., Alsafi, A., Almajnooni, R., Hasaballah, F., Alqarni, N. S., & Alsolami, M. A. (2018) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20182409
A Retrospective Cohort Study of Risk of Gallbladder Disease in Acute Cerebral Infarction Patients
Lee, S.-H., Kim, S., Jang, J., Lee, S. H., & Kim, Y. (2020) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2020.1.3
Glycemic Index, Glycemic Load, and Cancer Prevention
Philippou, E. (2016) · Figshare · doi:10.1201/9781315371764-15
Association of endometrial carcinoma with obesity and diabetes mellitus
Begum, S. A., Mahmud, T., & Amatullah, M. (2020) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v46i2.49022
Liu, L., Luo, H., Shu, Y., Liang, Y., & Tang, J.-L. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-00946-4 · Cited by 1
Grecian, S. M. (2021) · ERA · doi:10.7488/era/1218 · Cited by 1
Glycemic Index, Glycemic Load, and Cancer Prevention
Philippou, E. (2016) · CRC Press eBooks · doi:10.1201/9781315371764-8
Long-Term Statin Use and Risk of Breast Cancer—Letter
Goldstein, M. R., & Mascitelli, L. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0721
“Long-term observational data have indicated that diabetes is positively and significantly associated with all-cause and cancer mortality in women and men, including breast cancer in both women and men (4).”
BackgroundPlatz, E. A. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.07.014
Gaba, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-48662-8_1
Göke, B. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0875-4
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Neel, B. A., Antoniou, I. M., & LeRoith, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_36-1
Diabetes and Cancer: Treacherous Associations
Saxena, R., Naithani, M., & Saluja, R. (2022) · Journal of Cardio-diabetes and metabolic disorders · doi:10.4103/jcdm.jcdm_9_21
Rietz, M., Lehr, A., Mino, E., Lang, A. S., Szczerba, E., Schiemann, T., Herder, C., Saatmann, N., Geidl, W., Barbaresko, J., et al. (2022) · doi:10.2337/figshare.21158605.v1 · Cited by 1
Rietz, M., Lehr, A., Mino, E., Lang, A. S., Szczerba, E., Schiemann, T., Herder, C., Saatmann, N., Geidl, W., Barbaresko, J., et al. (2022) · doi:10.2337/figshare.21158605
Fahim, S. M., Qian, J., Hsu, C., Zeng, P., Lin, F., McDaniel, C. C., & Chou, C. (2023) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmad002
Data from Diabetes Risk Reduction Diet and Survival after Breast Cancer Diagnosis
Wang, T., Farvid, M. S., Kang, J. H., Holmes, M. D., ROSNER, B. A., Tamimi, R. M., Willett, W. C., & Eliassen, A. H. (2023) · doi:10.1158/0008-5472.c.6512928.v1
To explore the prevention and treatment of diabetic vascular diseases based on "Yingwei theory"
Li, R., Yue, L., Meng, L., Li, X., Chen, D., Guo, W., Chenyu, Z., & Yingmin, J. (2022) · International Conference on Information Technology in Medicine and Education · doi:10.1109/itme56794.2022.00021
Solano, C. D. C., Herrera, G. D. L. H., & Castilla-Velásquez, M. J. (2022) · Revista Biociencias · doi:10.18041/2390-0512/biociencias.2.10694
Elshanbary, A. A., Zaazouee, M. S., Nourelden, A. Z., Al‐kafarna, M., Matar, S. G., Elsaeidy, A. S., Ragab, K. M., Elhady, M. M., Albadrani, G. M., Altyar, A. E., et al. (2023) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000869
“One of the largest cohorts with the longest follow-up duration of 26 years had detected an increased breast cancer mortality rate in diabetic patients (Campbell et al. , 2012).”
BackgroundDiabetes Care in the Oncologic Population
Presswala, L. S., Farooki, A., & Flory, J. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_24
Hosoki, M., Hori, T., Kaneko, Y., Mori, K., Yasui, S., Tsuji, S., Yamagami, H., Kawata, S., Hara, T., Masuda, S., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051283
“…study was conducted at a single center with a relatively small sample size, and prospective studies are therefore needed to clarify the causes of death, morbidities, and how pharmaceuticals affect the age of death in individuals with and those without diabetes in the general community.”
BackgroundTriglyceride-glucose index and colorectal cancer risk and prognosis - a retrospective studyPreprint
Wang, H., Wang, S., Guo, H., & Feng, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4358086/v1
Çağlayan, M., & Eren, O. Ö. (2023) · doi:10.69860/nobel.9786053359111.43
Aro, A.-K., Karjalainen, M., Tiihonen, M., Kautiainen, H., Saltevo, J. T., Haanpää, M. L., & Mäntyselkä, P. T. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02651-7
“Previous studies have shown that patients with type 2 diabetes have a higher mortality rate compared with those without diabetes [28, 29] and the same connection is seen among older patients [30].”
Chen, H., Wang, X., Gao, J., Li, C., Zhong, W.-F., Huang, Q., Xie, J., Yang, J., Song, W.-Q., Liu, D., et al. (2026) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.70205
Lawrence, W. (2020) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/76w3-wfa9
Igbinosa, E. G., Dharmasekara, B., Quint, J. K., Popat, S., Bhaskaran, K., Morganstein, D. L., & Cook, S. (2025) · Clinical Epidemiology · doi:10.2147/clep.s498368
He, Y., Tao, Q., Zhou, F., Si, Y., Fu, R., Xu, B., Xu, J., Li, X., & Chen, B. (2021) · Figshare · doi:10.6084/m9.figshare.16821785
The critical role of oxalate in the liver-kidney axis and its effect on glucose metabolism
Gabrys, P. (2024) · Technische Universität Dortmund Eldorado (Technische Universität Dortmund) · doi:10.17877/de290r-24584
Mohammedi, K., Harrap, S., Mancia, G., Marre, M., Poulter, N. R., Chalmers, J. P., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.13520701
He, Y., Tao, Q., Zhou, F., 斯越秀, Fu, R., Xu, B., Xu, J., Li, X., & Chen, B. (2021) · Figshare · doi:10.6084/m9.figshare.16821788
Association of heart failure with multimorbidity and socioeconomic status
Scholten, M. (2024) · Lund University Publications (Lund University) · Cited by 1
Guðmundsson, K. (2023) · Skemman
Mortazavizadeh, S. M. R., Rafatmagham, S., & Rahimi, M. (2025) · Journal of Translational Medical Research · doi:10.61882/jbums.32.3.237
Diabetes mellitus and the risk of vulvar and vaginal cancer: results from a large cohort study
Aune, D., Chang, W., Macfarlane, T. V., Sobiecki, J. G., Hsieh, T., Hsu, W., Chang, F.-L., & He, M.-S. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04429-8
“Nevertheless, a history of diabetes is an established risk factor at least six other cancer types [18], and has established adverse impacts on a wide range of diseases and causes of death [34], thus adding up to a significant burden when assessing the evidence across a wider range of outcomes.”
Uncommon or Rare Forms of Diabetes: From Diagnosis to Management
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7878-0
Kandasamy, G., Arumugam, V., Orayj, K. M., Alanazi, T. S., Asiri, R., Alshahrani, A. M., Hmlan, A., Abumelha, M. S., Turki, I. A. M., Rani, V. I., et al. (2026) · Medicine · doi:10.1097/md.0000000000048787 · Cited by 1
“[6,7] Meta-analyses further suggest a 25% to 41% increase in cancer-related mortality among individuals with T2DM, [8-10] although findings remain inconsistent for certain cancer types, [11,12] underscoring the need for further investigation.”
Vidasov, N. (2021) · Institutional Repository of National University of Food Technologies
Dong, Z., Zhou, T., Ma, S., Chen, X., & Lai, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1945735
BindingDB Entry 50015597: Targeting SHP2 as a therapeutic strategy for inflammatory diseases.
BindingDB (2023) · UC San Diego · doi:10.7270/q2z60t09
Maharani, A., Sujarwoto, Praveen, D., Oceandy, D., Tampubolon, G., & Patel, A. (2024) · doi:10.1371/journal.pdig.0000476.r001
Self-citationChen, M.-L., Wu, C.-X., Zhang, J.-B., Zhang, H., Sun, Y.-D., Tian, S.-L., & Han, J.-J. (2022) · doi:10.3389/fendo.2022.996228.s002
Metadata
- Authors
- Campbell, P. T., Newton, C. C., Patel, A. V., Jacobs, E. J., & Gapstur, S. M.
- Affiliations
- American Cancer Society (US)
- Corresponding author
- Campbell, Peter T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1835-1844
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425000
- OpenAlex
- W1974792145
- Cited by
- 339
- References
- 41
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 26 · 2023: 16 · 2022: 27 · 2021: 31 · 2020: 33 · 2019: 13 · 2018: 35 · 2017: 27 · 2016: 26 · 2015: 25 · 2014: 22 · 2013: 23 · 2012: 8
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- diabetes mellitus, cause-specific mortality, cancer mortality, all-cause mortality, liver cancer, pancreatic cancer, breast cancer, colon cancer, endometrial cancer, bladder cancer, oral cavity and pharynx cancer, cardiovascular mortality, sex differences, Cancer Prevention Study II, prospective cohort, smoking, physical activity, body mass index
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Humans, Middle Aged, Neoplasms, Prospective Studies, Surveys and Questionnaires, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.